Qi Han
Jinan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Protective impact of circulating ω-3 PUFAs on sepsis susceptibility through PCSK9 variant: evidence from Mendelian randomization and animal experiments.
Journal: Frontiers in medicine
Published: September 08, 2025
Neutrophil ALDH2 is a new therapeutic target for the effective treatment of sepsis-induced ARDS.
Journal: Cellular & molecular immunology
Published: October 03, 2023
SUPER Score Contributes to Warning and Management in Early-Stage COVID-19.
Journal: Infectious medicine
Published: July 20, 2023
ALDH2 attenuates myocardial pyroptosis through breaking down Mitochondrion-NLRP3 inflammasome pathway in septic shock.
Journal: Frontiers in pharmacology
Published: December 16, 2022
The optimal anticoagulation strategy for COVID-19, prophylactic or therapeutic?: a meta-analysis, trial sequential analysis, and meta-regression of more than 27,000 participants.
Journal: Emergency and critical care medicine
Published: February 17, 2022
Current Evidence of Interleukin-6 Signaling Inhibitors in Patients With COVID-19: A Systematic Review and Meta-Analysis.
Journal: Frontiers in pharmacology
Published: October 10, 2020
The Role of ALDH2 in Sepsis and the To-Be-Discovered Mechanisms.
Journal: Advances in experimental medicine and biology
Published: August 02, 2019
ALDH2 Activation Inhibited Cardiac Fibroblast-to-Myofibroblast Transformation Via the TGF-β1/Smad Signaling Pathway.
Journal: Journal of cardiovascular pharmacology
Published: February 26, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026